Appelhans Dannielle 4
4 · Rubius Therapeutics, Inc. · Filed Feb 27, 2023
Insider Transaction Report
Form 4
Appelhans Dannielle
Chief Operating Officer
Transactions
- Sale
Common Stock
2023-02-24$0.13/sh−10,385$1,323→ 0 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1273 to $0.1274, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.